Humana (NYSE:HUM – Get Free Report) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday, Wall Street Zen reports.
Other equities research analysts also recently issued research reports about the company. Wolfe Research restated an “outperform” rating and issued a $450.00 target price on shares of Humana in a research report on Monday, August 24th. Barclays increased their price target on Humana from $515.00 to $582.00 and gave the stock an “overweight” rating in a report on Friday, October 9th. Evercore raised Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price objective for the company in a research report on Wednesday, July 29th. Royal Bank Of Canada boosted their price objective on shares of Humana from $246.00 to $415.00 and gave the company a “sector perform” rating in a report on Thursday, July 9th. Finally, Oppenheimer boosted their price objective on shares of Humana from $475.00 to $525.00 and gave the company an “outperform” rating in a report on Monday, October 12th. Twenty-one analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $453.30.
View Our Latest Stock Report on Humana
Humana Trading Down 0.1%
HUM stock opened at $421.56 on Friday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana has a 12-month low of $163.11 and a 12-month high of $456.50. The stock has a market cap of $50.62 billion, a price-to-earnings ratio of 39.88, a PEG ratio of 2.60 and a beta of 0.74. The business’s 50-day moving average is $397.95 and its 200 day moving average is $352.25.
Humana (NYSE:HUM – Get Free Report) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue for the quarter was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.27 earnings per share. On average, sell-side analysts anticipate that Humana will post 9.03 EPS for the current fiscal year.
Hedge Funds Weigh In On Humana
A number of hedge funds have recently modified their holdings of the business. BlackRock Inc. acquired a new stake in Humana during the 2nd quarter worth approximately $4,138,160,000. Pzena Investment Management LLC acquired a new position in shares of Humana in the second quarter valued at approximately $1,749,014,000. Assenagon Asset Management S.A. increased its holdings in shares of Humana by 20,126.8% in the third quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider’s stock valued at $479,053,000 after purchasing an additional 1,249,272 shares during the period. Legal & General Group Plc purchased a new stake in shares of Humana during the second quarter worth approximately $329,760,000. Finally, Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of Humana during the second quarter worth approximately $314,922,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
Humana Company Profile
Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.
Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.
Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.
Featured Stories
- Five stocks we like better than Humana
- Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story
- Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?
- Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
- Can Planet Fitness Get Its Growth Back in Shape?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
